Abstract
Leishmaniasis is an infectious disease caused by parasitic flagellates of the genus Leishmania. The authors present a case of 44-year-old man with Crohn's disease treated successfully with infliximab. This case report shows rare visceral leishmaniasis with cutaneous symptoms in an immunocompromised patient. Skin manifestations may occur before or after the visceral infection and they are often diverse.
Keywords:
immunosuppression; skin manifestation; visceral leishmaniasis.
© 2013 Wiley Periodicals, Inc.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anti-Inflammatory Agents / adverse effects*
-
Antibodies, Monoclonal / adverse effects*
-
Antiprotozoal Agents / adverse effects
-
Arrhythmias, Cardiac / chemically induced
-
Crohn Disease / diagnosis
-
Crohn Disease / drug therapy*
-
Crohn Disease / immunology
-
Fatal Outcome
-
Gastrointestinal Agents / adverse effects*
-
Humans
-
Immunocompromised Host
-
Infliximab
-
Leishmaniasis, Cutaneous / chemically induced*
-
Leishmaniasis, Cutaneous / diagnosis
-
Leishmaniasis, Cutaneous / drug therapy
-
Leishmaniasis, Cutaneous / immunology
-
Leishmaniasis, Cutaneous / parasitology
-
Leishmaniasis, Visceral / chemically induced*
-
Leishmaniasis, Visceral / diagnosis
-
Leishmaniasis, Visceral / drug therapy
-
Leishmaniasis, Visceral / immunology
-
Leishmaniasis, Visceral / parasitology
-
Male
-
Meglumine / adverse effects
-
Meglumine Antimoniate
-
Organometallic Compounds / adverse effects
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antiprotozoal Agents
-
Gastrointestinal Agents
-
Organometallic Compounds
-
Meglumine
-
Meglumine Antimoniate
-
Infliximab